MENU

IRD Opus Genetics Inc Forecast, Technical & Fundamental Analysis

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders... Show more

IRD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
IRD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics

Industry Biotechnology

Profile
Details
Industry
N/A
Address
8 Davis Drive
Phone
+1 984 884-6030
Employees
28
Web
https://www.opusgtx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLPGX46.890.52
+1.12%
Fidelity Advisor Low-Priced Stock Z
TWAIX14.710.12
+0.82%
Thrivent International Equity S
FSMEX50.90N/A
N/A
Fidelity Select Medical Tech and Devcs
MNHCX26.41N/A
N/A
Manning & Napier Pro-Blend Max Term L
VNIIX9.56N/A
N/A
Vontobel International Equity Inst

IRD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IRD has been loosely correlated with ARRY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IRD jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRD
1D Price
Change %
IRD100%
-0.49%
ARRY - IRD
35%
Loosely correlated
+1.54%
ROIV - IRD
34%
Loosely correlated
-0.29%
PRME - IRD
32%
Poorly correlated
-6.57%
NCEL - IRD
31%
Poorly correlated
+1.23%
DMAC - IRD
30%
Poorly correlated
N/A
More
Opus Genetics (IRD) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com